Gilead Sciences, Inc.

PHARMACEUTICAL FORMULATIONS COMPRISING TENOFOVIR ALAFENAMIDE AND EMTRICITABINE

Pharmaceutical Formulations Comprising Tenofovir Alafenamide And Emtricitabine

Pharmaceutical formulations comprising tenofovir alafenamide and emtricitabine

THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS

Pharmaceutical formulations and uses thereof

KRAS G12D MODULATING COMPOUNDS

SARS-COV2 MAIN PROTEASE INHIBITORS

HIV INHIBITOR COMPOUNDS

SUBSTITUTED PYRROLO[1,2-b]PYRIDAZINES AS BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES

PRMT5 INHIBITORS AND USES THEREOF

Compounds and methods for treatment of viral infections

CAPSID INHIBITORS FOR THE TREATMENT OF HIV

Substituted pyridotriazine compounds and uses thereof

1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF

Substituted 6-azabenzimidazole compounds

SOLID FORMS OF AN HIV CAPSID INHIBITOR

TOLL LIKE RECEPTOR MODULATOR COMPOUNDS

Compounds and methods for treatment of viral infections

Choline Salt Forms of an HIV Capsid Inhibitor

POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE

SOLID FORMS OF A TOLL-LIKE RECEPTOR MODULATOR

GLP-1R MODULATING COMPOUNDS

GLP-1R MODULATING COMPOUNDS

PROCESS FOR PREPARING A COT INHIBITOR COMPOUND

Diacylglycerol kinase modulating compounds

Antiviral compounds

COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

Nucleoside phosphoramidate prodrugs

Therapeutics compounds for HIV virus infection

SARS-COV2 main protease inhibitors

PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS

Methods and intermediates for preparing therapeutic compounds

ANTIVIRAL INDOLINYL COMPOUNDS AND USES THEREOF

HBV VACCINES AND METHODS TREATING HBV

SOLID FORMS OF A NUCLEOSIDE ANALOGUE AND USES THEREOF

COT MODULATORS AND METHODS OF USE THEREOF

Antibodies that target HIV GP120 and methods of use

PHOSPHOLIPID COMPOUNDS AND USES THEREOF

Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof

Tetracyclic compounds and uses thereof

LPA receptor antagonists and uses thereof

GLP-1R MODULATING COMPOUNDS

IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF

PARP7 INHIBITORS

Antiviral Pyrazolopiridinone Compounds

Salts and polymorphs of certain MCL-1 inhibitors

Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate

MCL1 inhibitors

Bridged tricyclic carbamoylpyridone compounds and uses thereof

Bridged tricyclic carbamoylpyridone compounds and uses thereof

SOLID FORMS OF A COT INHIBITOR COMPOUND

Nucleic acids encoding, and methods of producing, antibodies that bind human chemokine (C—C motif) receptor 8 (CCR8)

Capsid inhibitors for the treatment of HIV

MCL-1 inhibitors

Methods of preparing 1′-cyano nucleosides

IKAROS zinc finger family degraders and uses thereof

Compounds and methods for treatment of viral infections

1′-cyano nucleoside analogs and methods for treatment of viral infections

Compounds and methods for treatment of viral infections

Thienopyrrole compounds

Substituted pyrrolizine compounds and uses thereof

Substituted pyridotriazine compounds and uses thereof

PYRROLO[1,2-b]PYRIDAZINE DERIVATIVES

Phospholipid compounds and uses thereof

Phospholipid compounds and uses thereof

IKAROS zinc finger family degraders and uses thereof

Remdesivir treatment methods

Phospholipid compounds and methods of making and using the same

PD-1/PD-L1 INHIBITORS

LPA receptor antagonists and uses thereof

LPA receptor antagonists and uses thereof

Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof

THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION

Therapeutic compounds for HIV virus infection

Therapeutic compounds for HIV virus infection

Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use

Solid forms of FXR agonists

Substituted eneoxindoles and uses thereof

CD73 compounds

Compounds and methods for treatment of viral infections

BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF

METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS

Substituted pyrrolo[1,2-b]pyridazines as bifunctional degraders of interleukin-1 receptor-associated kinases

Diacylglyercol kinase modulating compounds

HBV vaccines and methods treating HBV

GLP-1R modulating compounds

Crystalline forms of tenofovir alafenamide

Inhibitors of peptidylarginine deiminases

KHK INHIBITORS

Diacylglycerol kinase modulating compounds

Diacylglycerol kinase modulating compounds

Multi-specific antigen binding molecules targeting HIV and methods of use

Diacylglycerol kinase modulating compounds

Quinoline derivatives

1′-cyano nucleoside analogs and uses thereof

CD73 compounds

Capsid inhibitors for the treatment of HIV